Last Updated: November 9, 2026

Aarxion Anda Hlding Company Profile

What is the competitive landscape for AARXION ANDA HLDING

AARXION ANDA HLDING has five approved drugs.

Summary for Aarxion Anda Hlding

US Patents:	0
Tradenames:	5
Ingredients:	5
NDAs:	5

Drugs and US Patents for Aarxion Anda Hlding

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Aarxion Anda Hlding	DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE	amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate	TABLET;ORAL	206721-006	Nov 10, 2015		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Aarxion Anda Hlding	BALSALAZIDE DISODIUM	balsalazide disodium	TABLET;ORAL	206336-001	Sep 8, 2015		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Aarxion Anda Hlding	CAPOTEN	captopril	TABLET;ORAL	018343-004	Jun 13, 1995		DISCN	Yes	No		⤷ Start Trial				⤷ Start Trial
Aarxion Anda Hlding	DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE	amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate	TABLET;ORAL	206721-001	Nov 10, 2015		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Aarxion Anda Hlding

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Aarxion Anda Hlding	CAPOTEN	captopril	TABLET;ORAL	018343-001	Approved Prior to Jan 1, 1982	5,238,924	⤷ Start Trial
Aarxion Anda Hlding	CAPOTEN	captopril	TABLET;ORAL	018343-005	Jan 17, 1985	4,105,776	⤷ Start Trial
Aarxion Anda Hlding	CAPOTEN	captopril	TABLET;ORAL	018343-002	Approved Prior to Jan 1, 1982	5,238,924	⤷ Start Trial
Aarxion Anda Hlding	CAPOTEN	captopril	TABLET;ORAL	018343-004	Jun 13, 1995	4,258,027	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Aarxion Anda Hlding

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.